2012 Global Lyme Disease Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country


April 20, 2012
203 Pages - SKU: VPG3867646
License type:
I. Introduction
II. Worldwide Market and Technology Overview
A. Background
0 Clinical Description
0 Clinical Case Definition
0 Laboratory Criteria for Diagnosis
0 Case Classification
B. Diagnostic Tests
C. Vaccines and Drugs
D. Emerging Diagnostic Technologies
1. DNA Probes
a. Technology Overview
b. Amplification Methods
0 Polymerase Chain Reaction
- Robotics
- Temperature Cyclers
- PCR Variations
0 Immuno-PCR
0 QC-PCR
0 DAP-PCR
0 Ligase Chain Reaction
0 Branched DNA
0 Q-Beta Replicase
0 Nucleic-Acid Sequence-Based
0 Strand Displacement Activation
0 Self-Sustained Sequence Replicase
2. Monoclonal Antibodies
3. Immunoassays
a. Technological Principle
b. Enzyme Immunoassays (EIA)
0 Overview
0 ELISA
0 Dot Immunobinding Assays
0 Capillary Immunoassays
0 Particle-Membrane Capture Immunoassays
0 Enzyme Amplification
c. Fluorescent Immunoassays
0 Fluorescence Polarization
0 Time-Resolved Pulse Fluorescence
d. Luminescence
0 Chemiluminescence
0 Bioluminescence
e. Latex Agglutination
f. Immunoprecipitation
4. Differential Light Scattering
5. Microcomputers and Automation
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. MRI
11. Gel Microdroplets
12. Other
III. France: Market Size, Growth and Major Suppliers’ Sales and Market Shares
IV. Germany: Test Volume and Diagnostics Sales Forecast by Market Segment
V. Italy: Test Volume and Diagnostics Sales Forecast by Market Segment
VI. Japan: Test Volume and Diagnostics Sales Forecast by Market Segment
VII. Spain: Market Size, Growth and Major Suppliers’ Sales and Market Shares
VIII. UK: Test Volume and Diagnostics Sales Forecast by Market Segment
IX. USA: Market Size, Growth and Major Suppliers’ Sales and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Applera
- Beckman Coulter
- Becton Dickinson
- Binding Site
- Biomerica
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Biosite
- Biotest
- Caliper Technologies
- Cepheid
- Chemicon
- Daiichi
- DiaSorin
- Diagast
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- Immunetics
- Innogenetics
- Inverness
- J&J
- Meridian
- Nanogen
- Nissui
- Olympus
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Tosho
- Trinity Biotech
- Tropix
- Wampole Labs
- Zenith
- Zeus


List of Tables
Major Companies Developing or Marketing Lyme Disease Tests


France Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
France Lyme Disease Testing Market Diagnostics Sales by Major Supplier


Germany Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment


Italy Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment


Japan Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment


Spain Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
Spain Lyme Disease Testing Market Diagnostics Sales by Major Supplier


U.K. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment


U.S.A. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lyme Disease Testing Market Diagnostics Sales by Major Supplier